These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 9655160)

  • 1. Increased endothelin-1 mRNA expression in peripheral blood monocytes of dialysis patients.
    Ebihara I; Nakamura T; Takahashi T; Tomino Y; Shimada N; Koide H
    Perit Dial Int; 1997; 17(6):595-601. PubMed ID: 9655160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endothelin-1 in continuous ambulatory peritoneal dialysis and hemodialysis patients: a preliminary study.
    Lightfoot BO; Caruana RJ
    Perit Dial Int; 1993; 13(1):55-8. PubMed ID: 8443279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metalloproteinase-9 mRNA expression in monocytes from patients with chronic renal failure.
    Ebihara I; Nakamura T; Tomino Y; Shimada N; Koide H
    Am J Nephrol; 1998; 18(4):305-10. PubMed ID: 9653834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interleukin-6 gene expression in peripheral blood mononuclear cells from patients undergoing hemodialysis or continuous ambulatory peritoneal dialysis.
    Takahashi T; Kubota M; Nakamura T; Ebihara I; Koide H
    Ren Fail; 2000 May; 22(3):345-54. PubMed ID: 10843245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preservation of residual renal function in dialysis patients: effects of dialysis-technique-related factors.
    Lang SM; Bergner A; Töpfer M; Schiffl H
    Perit Dial Int; 2001; 21(1):52-7. PubMed ID: 11280496
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
    Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
    J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship of pregnancy-associated plasma protein-a to renal function and dialysis modalities.
    Fialová L; Kalousová M; Soukupová J; Sulková S; Merta M; Jelínková E; Horejsí M; Srámek P; Malbohan I; Mikulíková L; Tesar V; Zima T
    Kidney Blood Press Res; 2004; 27(2):88-95. PubMed ID: 14739577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma myeloperoxidase, NT-proBNP, and troponin-I in patients on CAPD compared with those on regular hemodialysis.
    Al-Hweish A; Sultan SS; Mogazi K; Elsammak MY
    Hemodial Int; 2010 Jul; 14(3):308-15. PubMed ID: 20597992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased plasma lipoprotein(a) in continuous ambulatory peritoneal dialysis is related to peritoneal transport of proteins and glucose.
    Heimbürger O; Stenvinkel P; Berglund L; Tranoeus A; Lindholm B
    Nephron; 1996; 72(2):135-44. PubMed ID: 8684516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of hemostatic disturbances between patients on CAPD and patients on hemodialysis.
    Malyszko J; Malyszko JS; Mysliwiec M
    Perit Dial Int; 2001; 21(2):158-65. PubMed ID: 11330560
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma levels of human atrial natriuretic factor in patients treated by hemodialysis and continuous ambulatory peritoneal dialysis.
    Ando R; Matsuda O; Miyake S; Yoshiyama N
    Nephron; 1988; 50(3):225-8. PubMed ID: 2976122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of prolonged duration of different types of renal replacement therapies on serum levels of endothelin-1 and pulmonary function tests.
    Kovacevic P; Dragic S; Zlojutro B; Jandric M; Kovacevic T; Momcicevic D; Gasic B; Meyer J
    Folia Med (Plovdiv); 2021 Oct; 63(5):738-744. PubMed ID: 35851209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of plasma amino acid concentrations in end-stage renal disease patients on hemodialysis and peritoneal dialysis.
    Kim DH; Yang DH; Hong SY
    Korean J Intern Med; 1998 Feb; 13(1):33-40. PubMed ID: 9538629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of CAPD and hemodialysis on parathyroid function.
    Malberti F; Corradi B; Imbasciati E
    Adv Perit Dial; 1996; 12():239-44. PubMed ID: 8865912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Continuous ambulatory peritoneal dialysis is responsible for an increase in plasma norepinephrine.
    Vlachojannis JG; Tsakas S; Alexandri S; Petropoulou C; Goumenos DS
    Perit Dial Int; 2000; 20(3):322-7. PubMed ID: 10898050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superoxide dismutase and catalase activities in patients undergoing hemodialysis and continuous ambulatory peritoneal dialysis.
    Hernández de Rojas A; Mateo MC
    Ren Fail; 1996 Nov; 18(6):937-46. PubMed ID: 8948528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Expression of Fas on monocytes and the level of plasma soluble FasL in patients with chronic renal failure].
    Jiang J; Hou F; Liu Z; Liu J; Zhang X
    Zhonghua Nei Ke Za Zhi; 2001 Jan; 40(1):25-8. PubMed ID: 11798554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The determination of insulin sensitivity in hemodialysis and continuous ambulatory peritoneal dialysis in nondiabetic patients with end-stage renal disease.
    Tuzcu A; Bahceci M; Yilmaz ME; Turgut C; Kara IH
    Saudi Med J; 2005 May; 26(5):786-91. PubMed ID: 15951871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT dispersion in hemodialysis and CAPD patients.
    Kantarci G; Ozener C; Tokay S; Bihorac A; Akoğlu E
    Nephron; 2002 Aug; 91(4):739-41. PubMed ID: 12138280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combination therapy with hemodialysis and peritoneal dialysis.
    Suzuki H; Hoshi H; Inoue T; Kikuta T; Tsuda M; Takenaka T
    Contrib Nephrol; 2012; 177():71-83. PubMed ID: 22613917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.